https://orcid.org/0000-0002-0860-3100
References
- Kalogeropoulos D, Ch’ng SW, Lee R, et al. Optic disc pit maculopathy: a review. Asia Pac J Ophthalmol. 2019;8(3):247–255. doi:10.22608/APO.2018473
- Chatziralli I, Theodossiadis P, Theodossiadis GP. Optic disk pit maculopathy: current management strategies. Clin Ophthalmol. 2018;12:1417–1422. doi:10.2147/OPTH.S153711
- Bloch E, Georgiadis O, Lukic M, da Cruz L. Optic disc pit maculopathy: new perspectives on the natural history. Am J Ophthalmol. 2019;207:159–169. doi:10.1016/j.ajo.2019.05.010
- Bottoni F, Cereda M, Secondi R, Bochicchio S, Staurenghi G. Vitrectomy for optic disc pit maculopathy: a long-term follow-up study. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):675–682. doi:10.1007/s00417-018-3925-9
- Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82–118. doi:10.1016/j.preteyeres.2015.05.003
- Zhao M, Célérier I, Bousquet E, et al. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest. 2012;122(7):2672–2679. doi:10.1172/JCI61427DS1
- Ajlan RS, Hammamji KS. Stellate nonhereditary idiopathic foveomacular retinoschisis: response to topical dorzolamide therapy. Retin Cases Brief Rep. 2019;13(4):364–366. doi:10.1097/ICB.0000000000000599
- Genead MA, McAnany JJ, Fishman GA. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina. 2012;32(4):826–833. doi:10.1097/IAE.0b013e3182215ae9
- Das D, Nigam E. Resolution of cystoid macular edema by topical dorzolamide in a case of central serous chorioretinopathy: a case report. Med Vis Res Found. 2017;XXXV(3):25–26.
- Al-Moujahed A, Callaway NF, Vail D, Ludwig CA, Ji MH, Moshfeghi DM. Resolution of optic disc pit–associated macular retinoschisis after topical carbonic anhydrase inhibitor treatment: report of a case. Eur J Ophthalmol. 2020:112067212090466. doi:10.1177/1120672120904664